Cidara Therapeutics: $11.1M European Approval Milestoneby Mark Eisenberg 12.02.2024Cidara Therapeutics receives $11.1 million milestone payment from Mundipharma for European approval of new antifungal drug, Rezzayo. Analysts see potential ...
Temu’s Super Bowl Splash Challenges Retail Giantsby Lilu Anderson 12.02.2024Online retail platform Temu poses a competitive threat to Amazon with its aggressive marketing approach, highlighted by heavy investment in ...
Ethereum Gas Surge: ERC-404 Token Interestby John Darbie 12.02.2024Gas prices on the Ethereum network reached an eight-month high due to the popularity of ERC-404 tokens. Developers are working ...
Top Crypto Investments: Binance Coin (BNB), Ethereum (ETH), DeeStream (DST)by John Darbie 12.02.2024Discover the top crypto investments for investors, including Binance Coin (BNB), Ethereum (ETH), and DeeStream (DST). While BNB lacks trust ...
Ethereum’s ERC-404 Tokens Plummet: Trouble Ahead?by John Darbie 12.02.2024The highly-touted ERC-404 tokens on Ethereum have experienced a 29% drop in market capitalization, raising doubts about their viability and ...
Ethereum Founder’s $3K Price Buzzby John Darbie 12.02.2024Ethereum co-founder's 22,000 ETH deposit adds excitement to the market. Ethereum's positive trend, rumored Dencun upgrade, and potential climb to ...
Chainlink Surges, Dethroning Dogecoin in Top 10by John Darbie 12.02.2024Dogecoin drops out of the top 10 rankings, replaced by Chainlink. This reflects the growing interest in DeFi and the ...
Affirm’s Stock Sinking: Debating Valuation “Fruitless”by Mark Eisenberg 09.02.2024Affirm Holdings' stock surged 125% in three months before earnings report. Shares fell 13% after. Analysts have mixed ratings and ...
Bitcoin, Ethereum & Cryptos Surge in Asian Market on January 11by John Darbie 11.01.2024Ethereum price gains momentum as anticipation builds for ETH spot ETF